-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cellectar Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Cellectar Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13.3M, a 41.6% decline year-over-year.
- Cellectar Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$51.6M, a 52.4% decline year-over-year.
- Cellectar Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$39M, a 35.2% decline from 2022.
- Cellectar Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$28.8M, a 19.4% decline from 2021.
- Cellectar Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$24.1M, a 57.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)